Skip to main content Back to Top
Advertisement

Telehealth: Connecting Clinical Pharmacists with Patients in Palliative Care

January 11, 2024

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

The emergence of healthcare delivery during the COVID-19 pandemic demonstrated the potential advantages of leveraging technology to bring the clinician to the patient. Telehealth remains a viable and sustainable option for patients that have limited access to in-person care. Palliative care teams can utilize technology to optimize access and delivery of clinical pharmacy services to patients in palliative care.

SPEAKERS

Jessica GeigerJessica Geiger, PharmD, MS, BCPS has been passionate about palliative care, hospice and pain management from the beginning of her professional career. She actively sought out opportunities to learn more about these topics during pharmacy school, her residency and early career. Now she teaches on them at the local, state, national and international levels. Additionally she began a PGY2 residency and has precepted numerous pharmacy and medical students, and residents. Dr Geiger has been and will continue to be an advocate for the pharmacists role on palliative, hospice and pain management teams.

Vinh DaoVinh Dao (Vinny), PharmD, BCPS completed his Doctorate of Pharmacy at the University of Minnesota College of Pharmacy. Dr. Dao currently serves as TelePain Program Manager for the VA Midwest Health Care Network (VISN 23). He has provided specialty clinical pharmacy services in the areas of pain management, opioid stewardship, and headache disorder. He served as RPD to build a PGY2 Pain Management and Palliative Care Residency Program and has been published in peer reviewed journals.


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.